Table 2.
Secondary outcomes: mean values for participants who visited at least once after randomisation.
| Control group | Active group | Mean difference (95% CI) | P-value χ2 | |
|---|---|---|---|---|
| MiniAQLQ scorea | ||||
| Baseline | 4.8 | 4.9 | ||
| Final | 5.8 | 6.3 | ||
| Change | 1.02 | 1.37 | 0.35 (−0.3 to 1) | P = 0.3 |
| ACQ scorea | ||||
| Baseline | 1.9 | 1.8 | ||
| Final | 1.25 | 1.0 | ||
| Change | −0.65 | −0.80 | 0.15 (−0.5 to 0.7) | P = 0.6 |
| FEV1 (L) | ||||
| Baseline | 2.46 | 2.86 | ||
| Average | 2.51 | 2.91 | ||
| Difference between baseline and average | 0.05 | 0.05 | 0.01 (−0.2 to 0.2) | P = 0.9 |
| Final | 2.47 | 2.88 | ||
| Difference between baseline and final FEV1 | 0.04 | 0.05 | 0.01 (−0.2 to 0.2) | P = 0.9 |
| Number of participants visiting GP/total number of GP visits | 6/12 | 5/6 | P = 0.27 | |
| Number of participants prescribed oral steroids/total number of oral steroid courses | 3/6 | 4/6 | P = 0.63 | |
a
Increase in the MiniAQLQ score and a reduction in the ACQ score denotes improved asthma control. MiniAQLQ = Mini Asthma Quality of Life Questionnaire. ACQ = Asthma Control Questionnaire. FEV1 = Forced expiratory volume in 1 second.